Rompag 25 mg – Restoring Lives in Severe Aplastic Anaemia | |
Rompag 25 mg Tablet is indicated for the treatment of low platelet counts in patients with chronic immune thrombocytopenic purpura (ITP) and those with chronic hepatitis C virus (HCV) infection. It is also effective in managing severe aplastic anaemia. As a thrombopoietin receptor agonist, Rompag works by stimulating the production of new platelets, which play a critical role in minimizing bleeding and supporting blood health. To know more check out: https://www.heterohealthcare.com/rompag-25-mg-tablets ![]() | |
Target Nation: All Nations Target City : Madhapur,Telengana Last Update : 17 April 2025 7:31 PM Number of Views: 14 | Item Owner : Hetero Healthcare Contact Email: Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |